Where is the live CopyMark page for USPTO serial 79290060?

The live record is at https://getcopymark.com/trademark/79290060. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns PROCESSED WITH BIO MATRIX TECHNOLOGY?

According to the public USPTO record for serial number 79290060, the listed owner(s) include: Australian Biotechnologies Pty Limited, Australian Biotechnologies Pty Limited, Australian Biotechnologies Pty Limited.

What is USPTO serial number 79290060?

Serial number 79290060 is the USPTO application identifier for the mark PROCESSED WITH BIO MATRIX TECHNOLOGY. It is used to track examination, publication, and registration of this trademark.

What is the current status of PROCESSED WITH BIO MATRIX TECHNOLOGY?

PROCESSED WITH BIO MATRIX TECHNOLOGY (79290060) currently shows USPTO status code 404 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover PROCESSED WITH BIO MATRIX TECHNOLOGY?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: PROCESSED WITH BIO MATRIX TECHNOLOGY Serial# 79290060 | status 404; last event DENC | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PROCESSED WITH BIO MATRIX TECHNOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James A. Sheridan

James A. Sheridan Sheridan Law, LLC1019 8th StreetSuite 100Golden, CO 80401

Goods and services

Class	Description	Status	First use
005	Biological tissue cultures for medical purposes; guided tissue regeneration materials, namely, implants comprising living tissue; implant materials for use in guided tissue regeneration in surgery, namely, implants comprising living tissue; implantable textile material comprising living tissue to encourage the growth of tissue; implants for guided tissue regeneration, namely, implants comprising living tissue; surgical grafts comprised of living tissues; surgical implants comprised of living tissues; surgical implants grown from stem cells comprised of living tissues; tissue-regenerative medical preparations; transplants comprised of living tissues, namely, implants comprising living tissue, biological tissue grafts; materials for use in guided tissue regeneration, namely, implants comprising living tissue	SECTION 70 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Jul 31, 2022	DENC	NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED	—
Jul 31, 2022	DETH	DEATH OF INTERNATIONAL REGISTRATION	—
Jun 25, 2022	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
Nov 29, 2021	FINV	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Nov 6, 2021	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Nov 5, 2021	FIMP	FINAL DISPOSITION PROCESSED	—
Oct 6, 2021	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Jul 6, 2021	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 20, 2021	NPUB	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	—
Apr 20, 2021	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 18, 2021	GPNX	NOTIFICATION PROCESSED BY IB	—
Mar 31, 2021	OPNS	NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB	—
Mar 31, 2021	OP2R	NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB	—
Mar 31, 2021	NONP	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	—
Mar 17, 2021	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Mar 17, 2021	XAEC	EXAMINER'S AMENDMENT ENTERED	—
Mar 17, 2021	GNEN	NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	—
Mar 17, 2021	GNEA	EXAMINERS AMENDMENT E-MAILED	—
Mar 17, 2021	CNEA	EXAMINERS AMENDMENT -WRITTEN	—
Mar 2, 2021	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Mar 2, 2021	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Mar 2, 2021	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 2, 2020	RFNT	REFUSAL PROCESSED BY IB	—
Oct 9, 2020	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Oct 9, 2020	RFRR	REFUSAL PROCESSED BY MPU	—
Sep 22, 2020	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Sep 21, 2020	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 17, 2020	DOCK	ASSIGNED TO EXAMINER	—
Jul 28, 2020	MAFR	APPLICATION FILING RECEIPT MAILED	—
Jul 24, 2020	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Jul 23, 2020	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

PROCESSED WITH BIO MATRIX TECHNOLOGY